Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct 28;6(10):e1001067.
doi: 10.1371/journal.ppat.1001067.

Antimicrobial peptides: primeval molecules or future drugs?

Affiliations
Review

Antimicrobial peptides: primeval molecules or future drugs?

Brian M Peters et al. PLoS Pathog. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Protein models representing the structural differences of the four classes of antimicrobial peptides.
Antimicrobial peptides can be grouped into four major classes based on their secondary structures, including the (A) α-helical peptides, (B) peptides composed of a series of β-sheets, (C) peptides that adopt unconventional structures, such as extended helices, and (D) peptides that assemble into loops. All structures were obtained freely from the RCSB Protein Data Bank (PDB) (http://www.pdb.org/) and have been referenced according to their Digital Object Identifier (DOI) . Additional information for each AMP may be obtained by consulting the RCSB PDB and cross-referencing the DOI.
Figure 2
Figure 2. The proposed diverse mechanistic modes of action for antimicrobial peptides in microbial cells.
(A) Disruption of cell membrane integrity: (1) random insertion into the membrane, (2) alignment of hydrophobic sequences, and (3) removal of membrane sections and formation of pores. (B) Inhibition of DNA synthesis. (C) Blocking of RNA synthesis. (D) Inhibition of enzymes necessary for linking of cell wall structural proteins. (E) Inhibition of ribosomal function and protein synthesis. (F) Blocking of chaperone proteins necessary for proper folding of proteins. (G) Targeting of mitochondria: (1) inhibition of cellular respiration and induction of ROS formation and (2) disruption of mitochondrial cell membrane integrity and efflux of ATP and NADH.

References

    1. Giuliani A, Pirri G, Nicoletto S. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol. 2007;2:1–33.
    1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–395. - PubMed
    1. Shai Y. From innate immunity to de-novo designed antimicrobial peptides. Curr Pharm Des. 2002;8:715–725. - PubMed
    1. Bals R, Wilson JM. Cathelicidins–a family of multifunctional antimicrobial peptides. Cell Mol Life Sci. 2003;60:711–720. - PMC - PubMed
    1. Kavanagh K, Dowd S. Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol. 2004;56:285–289. - PubMed

Publication types

MeSH terms